Abstract
Smad proteins transduce signals for transforming growth factor-β (TGF-β)-related factors1. Smad proteins activated by receptors for TGF-β form complexes with Smad4. These complexes are translocated into the nucleus and regulate ligand-indu ced gene transcription2,3,4. 12- O-tetradecanoyl-13-acetate (TPA)-responsive gene promoter elements (TREs) are involved in the transcriptional responses of several genes to TGF-β (5–8). AP-1 transcription factors, composed of c-Jun and c-Fos, bind to and direct transcription from TREs, which are therefore known as AP1-binding sites9. Here we show that Smad3 interacts directly with the TRE and that Smad3 and Smad4 can activate TGF-β-inducible transcription from the TRE in the absence of c-Jun and c-Fos. Smad3 and Smad4 also act together with c-Jun and c-Fos to activate transcription in response to TGF-β, through a TGF-β-inducible association of c-Jun with Smad3 and an interaction of Smad3 and c-Fos. These interactions complement interactions between c-Jun and c-Fos, and between Smad3 and Smad4. This mechanism of transcriptional activation by TGF-β, through functional and physical interactions between Smad3–Smad4 and c-Jun–c-Fos, shows that Smad signalling and MAPK/JNK signalling converge at AP1-binding promoter sites.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Heldin, C. H., Miyazono, K. & ten Dijke, P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465– 471 (1997).
Lagna, G., Hata, A., Hemmati-Brivanlou, A. & Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832–836 (1996).
Zhang, Y., Feng, X.-H., Wu, R.-Y. & Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168–172 ( 1996).
Zhang, Y., Musci, T. & Derynck, R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr. Biol. 7, 270– 276 (1997).
de Groot, R. P. & Kruijer, W. Transcriptional activatin by TGF-β mediated by the DYAD symmetry element (DSE) and the TPA responsive element (TRE). Biochem. Biophys. Res. Commun. 168, 1074–1081 (1990).
Keeton, M. R., Curriden, S. A., van Zonneveld, A. & Loskutoff, D. J. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266, 23048–23052 (1991).
Jin, G. & Howe, P. H. Regulation of clusterin gene expression by transforming growth factor β. J. Biol. Chem. 272, 26620–26626 (1997).
Felts, S. J., Stoflet, E. S., Eggers, C. T. & Getz, M. J. Tissue factor gene transcription in serum-stimualted fibroblasts is mediated by recruitment of c-Fos into specific AP-1 DNA-binding complexes. Biochemistry 34, 12355–12362 (1995).
Angel, P. & Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129–157 ( 1991).
Wrana, J. L. et al. TGF-β signals though a heteromeric protein kinase receptor complex. Cell 71, 1003– 1014 (1992).
Nakao, A. et al. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353– 5362 (1997).
Renshaw, M. W., McWhirter, J. R. & Wang, J. Y. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15, 1286– 1293 (1995).
Angel, P. et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729–739 (1987).
Wu, R.-Y., Zhang, Y., Feng, X.-H. & Derynck, R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol. 17, 2521–2528 (1997).
Chiu, R. et al. The c-Fos protein interacts wit c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541– 552 (1988).
Yang-Yen, H. F., Chiu, R. & Karin, M. Elevationof AP-1 activity during F9 cell differentiation is due to increased c-Jun transcription. New Biol. 2, 351– 361 (1990).
Feng, X.-H., Zhang, Wu, R.-Y. & Derynck, R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12, 2153–2163 (1998).
Hata, A., Lo, R. S., Wotton, D., Lagna, G. & Massagué, J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388, 82–87 (1997).
Liu, F. et al. Ahuman Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620–623 ( 1996).
Feng, X.-H., Filvaroff, E. H. & Derynck, R. TGF-β-induced down-regulation of cyclin A expression requries a functional TGF-β receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 270, 24237–24245 (1995).
Yoshizumi, M. et al . Down-regulation of the cyclin A promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein. J. Biol. Chem. 272, 22259– 22264 (1997).
Yingling, J. M. et al . Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol. Cell. Biol. 17, 7019–7028 (1997).
Zawel, L. et al. Human Smad3 and Smad4 are sequence-specific transcription activator. Mol. Cell 1, 611–176 (1998).
Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483–16486 (1995).
Lloyd, A., Yancheva, N. & Wasylyk, B. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352, 635–638 (1991).
Kretzschmar, M., Doody, J. & Massagué, J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389, 618–622 (1997).
de Caestecker, M. P. et al. Smad2 transduces common signals from serine-threonine and tyrosine kinases. Genes Dev. 1 2, 1587 –1592 (1998).
Graycar, J. L. et al . Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factor-β1 and -β2. Mol. Endocrinol. 3, 1977–1986 (1989).
Sadowski, I. & Ptashne, M. Avector for expressing GAL4(1–147) fusions in mammalian cells. Nucleic Acids Res. 17, 7539 (1989).
Feng, X.-H. & Derynck, R. Ligand-independent activationof TGF-β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors. J. Biol. Chem. 271, 13123– 13129 (1996).
Acknowledgements
This research was supported by the NIH (R.D.) and postdoctoral fellowships from the American Lung Association (to Y.Z.) and the American Cancer Society (to X-H.F.). We thank J.Massagué, J. Wrana and L. Attisano, M. Karin, D. Loskutoff, J. Wang, K. Yamamoto, P. Kushner, X.-F. Wang, P. ten Dijke, M.Green, M. Ptashne and R. Tijan for valuable reagents, and M. Cronin and L. Choy for reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Y., Feng, XH. & Derynck, R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909–913 (1998). https://doi.org/10.1038/29814
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/29814
This article is cited by
-
Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets
Molecular Medicine (2024)
-
SMAD2/3 signaling in the uterine epithelium controls endometrial cell homeostasis and regeneration
Communications Biology (2023)
-
Long non coding RNAs reveal important pathways in childhood asthma: a future perspective
Journal of Molecular Histology (2023)
-
NetAct: a computational platform to construct core transcription factor regulatory networks using gene activity
Genome Biology (2022)
-
TGF-beta signal transduction: biology, function and therapy for diseases
Molecular Biomedicine (2022)